An analysis of three different prostate cancer risk calculators applied prior to prostate biopsy: A Turkish cohort validation study-Reference-Cited by-同舟云学术

An analysis of three different prostate cancer risk calculators applied prior to prostate biopsy: A Turkish cohort validation study

Published:2021-11-27 Issue: Volume: Page:
ISSN:0303-4569
Container-title:Andrologia
language:en
Short-container-title:Andrologia

Author:

Yıldızhan Mehmet¹^ORCID,Balcı Melih¹,Eroğlu Unsal¹,Asil Erem¹,Coser Seref¹,Özercan Ali Yasin¹,Köseoğlu Burak¹,Güzel Ozer¹,Asfuroğlu Ahmet²,Tuncel Altuğ³^ORCID

Affiliation:

1. Department of Urology Ankara City Hospital Ankara Turkey

2. Department of Urology Ankara Etimesgut State Hospital Ankara Turkey

3. Department of Urology affiliated with Ankara City Hospital Faculty of Medicine University of Health Sciences Ankara Turkey

Publisher

Wiley

Subject

Urology,Endocrinology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/and.14329

Reference24 articles.

1. ‘Prostate Cancer Risk Calculator’ mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS)

2. Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer

3. A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts

4. Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer

5. A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi‐ethnic cohort;Carbunaru S.;BMC Urology,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk calculators for the detection of prostate cancer: a systematic review;Prostate Cancer and Prostatic Diseases;2024-06-03

2. ZNF692 promotes cell proliferation, invasion and migration of human prostate cancer cells by targeting the EMT signaling pathway;European Journal of Medical Research;2024-01-30

3. Accommodating heterogeneous missing data patterns for prostate cancer risk prediction;BMC Medical Research Methodology;2022-07-21